Women who smoke during the first trimester of pregnancy increase the risk of their offspring developing certain congenital heart defects by 20% to 70%.
Women who smoke during the first trimester of pregnancy increase the risk of their offspring developing certain congenital heart defects by 20% to 70%, according to the findings of the Baltimore-Washington Infant Study, the first population-based, case-control study of congenital heart defects conducted in the US.
Researchers from the Centers for Disease Control and Prevention (CDC) in Atlanta, Georgia, analyzed 2,525 case infants and 3,435 control infants born between 1981 and 1989 in Maryland, Washington, DC, and select counties in Virginia. Odds ratios (OR) for self-reported, first-trimester maternal cigarette smoking and the risk for various types of defects were as follows (all 95% CI): secundum-type atrial septal defects, 1.36 (1.04–1.78); right ventricular outflow tract defects, 1.32 (1.06–1.65); pulmonary valve stenosis, 1.35 (1.05-1.74); truncus arteriosus, 1.90 (1.04–3.45); and levo-transposition of the great arteries, 1.79 (1.04–3.10).
In addition, the results suggested an increased risk for atrioventricular septal defects among infants without Down syndrome (OR 1.50; 95% CI, 0.99–2.29).
Alverson CJ, Strickland MJ, Gilboa SM, Correa A. Maternal smoking and congenital heart defects in the Baltimore-Washington Infant Study. Pediatrics. 2011;127(3):e647-e653.
Hormone therapy safety: Study finds potential benefits for senior women
April 24th 2024A recent large-scale study challenged age-related concerns, suggesting hormone therapy may offer safety and even benefits for menopausal women aged over 65 years, aligning with The Menopause Society's 2022 Position Statement.
Read More
Hyperoxygenation use not linked to neonatal outcomes
April 23rd 2024Recent research evaluated the impact of maternal hyperoxygenation on neonatal Apgar scores, revealing no significant enhancement in outcomes among women with pathologic fetal heart rate tracing and suggesting limited efficacy of hyperoxygenation therapy in this context.
Read More
Study finds antihypertensive treatment reduces uterine fibroids risk
April 23rd 2024A recent study revealed that patients with untreated or new-onset hypertension face elevated chances of uterine fibroid diagnosis, underscoring the potential of antihypertensive therapy in mitigating this risk among midlife individuals.
Read More